参考文献/References:
[1]Yu XJ,Liang MF,Zhang SY,et al.Fever with thrombocytopenia associated with a novel bunyavirus in China[J].N Engl J Med,2011,364(16):1523-1532.[2]Gong L,Song DD,Wu JB,et al.Human-to-human transmissions of severe fever with thrombocytopenia syndrome virus in Anhui province,2010-2017[J].Clin Microbiol Infect,2018,24(8):920-922.[3]Wang Y,Han S,Ran R,et al.A longitudinal sampling study of transcriptomic and epigenetic profiles in patients with thrombocytopenia syndrome[J].Nat Commun,2021,12(1):5629.[4]Liu Q,He B,Huang SY,et al.Severe fever with thrombocytopenia syndrome,an emerging tick-borne zoonosis[J].Lancet Infect Dis,2014,14(8):763-772.[5]袁春,崔宁,王炳军,等.253例发热伴血小板减少综合征的临床表现特征[J].中国现代医学杂志,2011,21(27):3413-3417.[6]姜晓林,丁淑军,逄博,等.山东省发热伴血小板减少综合征实验室确诊病例临床与流行特征分析[J].中国人兽共患病学报,2017,33(12):1077-1081.[7]叶重阳,张荣荣,梅清,等.轻症与重症新型布尼亚病毒感染临床和实验室指标差异分析[J].中国急救复苏与灾害医学杂志,2020,15(7):847-849.[8]毛雪兰,邓宝成.重症发热伴血小板减少综合征临床特征分析[J].中国全科医学,2019,22(24):2979-2984.[9]Park SY,Kwon JS,Kim JY,et al.Severe fever with thrombocytopenia syndrome-associated encephalopathy/ encephalitis[J].Clin Microbiol Infect,2018,24(4):432.e1-432.e4.[10]Gai ZT,Zhang Y,Liang MF,et al.Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients[J].J Infect Dis,2012,206(7):1095-1102.[11]音铭,赵宗豪,杨云.95例发热伴血小板减少综合征患者死亡危险因素分析[J].安徽卫生职业技术学院学报,2020,19(4):21-23,25.[12]王宁,张伟,段建平,等.发热伴血小板减少综合征神经系统受累患者的临床特征[J].中国感染控制杂志,2018,17(11):958-964.[13]Kaneko M,Shikata H,Matsukage S,et al.A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system[J].J Infect Chemother,2018,24(4):292-297.[14]Li H,Lu QB,Xing B,et al.Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study[J].Lancet Infect Dis,2018,18(10):1127-1137.[15]谭婷婷,徐志晔,王森,等.117例发热伴血小板减少综合征患者临床特征分析[J].临床检验杂志,2020,38(4):313-316.[16]周麟玲,贾荣娟,董崇林,等.高新型布尼亚病毒载量发热伴血小板减少综合征患者141例的临床特征及预后影响因素分析[J].中华传染病杂志,2020,38(9):578-583.[17]李文.发热伴血小板减少综合征流行病学特点与临床特征分析[J].中国病原生物学杂志,2017,12(9):901-904.[18]林绿华,张照如.发热伴血小板减少综合征重症患者的早期预警指标分析[J].医学信息,2021,34(7):167-169,173.[19]Hirofumi K,Takuya Y,Tomoe S,et al.Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013-2014[J].PLoS One,2016,11(1):e0165207.[20]李金娥,牛同红.发热伴血小板减少综合征早期实验室指标与预后的相关性[J].安徽医学,2019,40(4):426-429.[21]Wang L,Zou Z,Hou C,et al.Score risk model for predicting severe fever with thrombocytopenia syndrome mortality[J].BMC Infect Dis,2017,17(1):42.[22]Yang B,Wang X,Li Y,et al.A Newly Established Severity Scoring System in Predicting the Prognosis of Patients with Severe Fever with Thrombocytopenia Syndrome[J].Tohoku J Exp Med,2017,242(1):19-25. [23]李强,孙桂静,邓宝成.98例发热伴血小板减少综合征患者死亡相关危险因素分析[J].辽宁医学杂志,2017,31(6):35-37.[24]韩常新,孙艾军,蒲春文,等.新型布尼亚病毒感染致发热伴血小板减少综合征的流行病学特征及预后影响指标分析[J].中华医院感染学杂志,2019,29(2):171-174,187.[25]Chen Y,Jia B,Liu Y, et al.Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis[J].Oncotarget,2017,8(51):89119-89129.[26]方欣玉,张楠,李志峰,等.发热伴血小板减少综合征血清SFTSV中和抗体消长及影响因素[J].国际病毒学杂志,2020,27(3):219-223.[27]Song P,Zheng N,Liu Y,et al.Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection[J].Nat Commun,2018,9(1):3328.[28]Li MM,Zhang WJ,Weng XF,et al.CD4 T cell loss and Th2 and Th17 bias are associated with the severity of severe fever with thrombocytopenia syndrome (SFTS)[J].Clin Immunol,2018,195:8-17.[29]Zhang L,Fu Y,Wang H,et al.Severe Fever With Thrombocytopenia Syndrome Virus-Induced Macrophage Differentiation Is Regulated by miR-146[J].Front Immunol,2019,10:1095.[30]Liu MM,Lei XY,Yu H,et al.Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome[J].Virol J,2017,14(1):6.[31]王青,李伯利,陈葆国,等.发热伴血小板减少综合征六例患者骨髓形态学特点及其临床意义[J].中华传染病杂志,2015,33(5):266-270.[32]Kim N,Kim KH,Lee SJ,et al.Bone marrow findings in severe fever with thrombocytopenia syndrome:prominent haemophagocytosis and its implication in haemophagocytic lymphohistiocytosis[J]. J Clin Pathol, 2016,69(6):537-541.[33]方汉波.发热伴血小板减少综合征28例骨髓象特征分析[J].中华临床感染病杂志,2016,9(3):260-264.[34]刘超群,吴茅.新型布尼亚病毒感染患者骨髓见戒指样组织细1例[J].临床检验杂志,2017,35(2):159-160.[35]陈德颖,吕涛,黄晓霞.2011-2017年威海市发热伴血小板减少综合征监测结果分析[J].国际病毒学杂志,2019,26(3):165-168.[36]彭蕾,汤磊,张振华,等.红细胞分布宽度预测发热伴血小板减少综合征预后的临床价值[J].安徽医药,2021,25(3):500-503.
相似文献/References:
[1]孙朝霞,曹显刚,赵 利,等.发热伴血小板减少综合征患者D-二聚体、心肌酶谱及肝酶谱的检测[J].医学信息,2018,31(03):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
SUN Zhao-xia,CAO Xian-gang,ZHAO li,et al.Detection of D-Dimer,Myocardial and Liver Enzymes in Patients with Fever and Thrombocytopenia Syndrome[J].Journal of Medical Information,2018,31(06):85.[doi:10.3969/j.issn.1006-1959.2018.03.026]
[2]樊梦思,赵 红,余业洲,等.发热伴血小板减少综合征临床及影像表现分析[J].医学信息,2020,33(14):174.[doi:10.3969/j.issn.1006-1959.2020.14.058]
FAN Meng-si,ZHAO Hong,YU Ye-zhou,et al.Analysis of Clinical and Imaging Manifestations of Fever with Thrombocytopenia Syndrome[J].Journal of Medical Information,2020,33(06):174.[doi:10.3969/j.issn.1006-1959.2020.14.058]
[3]林绿华,张照如.发热伴血小板减少综合征重症患者的早期预警指标分析[J].医学信息,2021,34(07):167.[doi:10.3969/j.issn.1006-1959.2021.07.048]
LIN Lv-hua,ZHANG Zhao-ru.Analysis of Early Warning Indicators for Severe Fever with Thrombocytopenia Syndrome[J].Journal of Medical Information,2021,34(06):167.[doi:10.3969/j.issn.1006-1959.2021.07.048]
[4]刘旗旗,张照如.发热伴血小板减少综合征的死亡预测模型建立[J].医学信息,2023,36(11):21.[doi:10.3969/j.issn.1006-1959.2023.11.004]
LIU Qi-qi,ZHANG Zhao-ru.Establishment of Death Prediction Model for Severe Fever with Thrombocytopenia Syndrome[J].Journal of Medical Information,2023,36(06):21.[doi:10.3969/j.issn.1006-1959.2023.11.004]